Synedica Klow Skin 80mg Pen is a combination research formulation developed for laboratory investigations involving skin biology, tissue recovery, and regenerative pathways.

According to the product packaging, the formulation contains:

• 48mg GHK-Cu
• 10mg BPC-157
• 10mg TB-500
• 10mg KPV
• 2mg Vitamin B12

The pen contains a total labelled formulation of 80mg and is presented as 20 × 4mg doses.

Research interest surrounding the individual components includes studies of skin-related biological processes, cellular signalling, tissue response, and recovery pathways.

This product is supplied in a pen format for controlled research environments.

Key Features

• Synedica Klow Skin 80mg formulation
• Multi-compound peptide research formulation
• Contains 48mg GHK-Cu
• Contains 10mg BPC-157
• Contains 10mg TB-500
• Contains 10mg KPV
• Contains 2mg Vitamin B12
• 80mg total formulation
• 20 × 4mg doses as stated on packaging
• Convenient pre-filled pen format

How to Use (Research Reference Only)

This product is intended exclusively for laboratory and scientific research conducted by qualified professionals following appropriate institutional research protocols.

Not intended for human consumption or self-administration.

Research Applications

The individual components are commonly investigated in research relating to:

• Skin and tissue biology
• Cellular signalling
• Regenerative pathway research
• Tissue recovery studies
• Inflammatory pathway research
• Peptide interaction studies
• Biological response modelling

Research Disclaimer

For laboratory and scientific research use only.

Not intended for human consumption, therapeutic use, or medical application.

What is Synedica Klow Skin 80mg?

Synedica Klow Skin 80mg is a multi-compound formulation containing GHK-Cu, BPC-157, TB-500, KPV, and Vitamin B12. The combination is designed for research involving skin biology, tissue recovery, cellular signalling, and related biological pathways.